Novavax touts non\u002DmRNA COVID\u002D19 vaccine, hopeful to meet domestic production deadline

Indonesia Berita Berita

Novavax touts non\u002DmRNA COVID\u002D19 vaccine, hopeful to meet domestic production deadline
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 TheStarPhoenix
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 63%

The new formulation is awaiting Health Canada approval.

OTTAWA — The last remaining manufacturer to offer an alternative to mRNA COVID-19 vaccines in Canada is hopeful it will meet the government’s 2024 deadline to make the shots domestically.

“That will then lead into what we hope will be full bulk antigen manufacturing in 2024,” Boston said at the press conference Wednesday, which was held over video conference.This summer, Ottawa amended its purchasing agreement with Novavax, and now has the ability to end the deal if bulk production doesn’t start by the end of 2024, documents filed to the U.S. Securities and Exchange Commission show.

Novavax is one of only four manufacturers with COVID-19 vaccines that are approved for use in Canada. “Therefore Novavax’s protein-based vaccine represents the only non-mRNA vaccine option, which I think people will need to be aware of.”

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

TheStarPhoenix /  🏆 253. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Kevin Spacey Gives Health Update After Recent Health ScareKevin Spacey Gives Health Update After Recent Health ScareActor Kevin Spacey recently revealed that he underwent a health scare during a trip overseas for a film festival.
Baca lebih lajut »

75,000 Kaiser health workers strike in five states in largest health care walkout in U.S. history75,000 Kaiser health workers strike in five states in largest health care walkout in U.S. historySome 75,000 Kaiser Permanente workers took to picket lines in five states and Washington, D.C. on Wednesday in the largest health care work stoppage in U.S. history.
Baca lebih lajut »

75,000 Kaiser Permanente Health Care Workers Launch Largest Health Care Strike in US History75,000 Kaiser Permanente Health Care Workers Launch Largest Health Care Strike in US HistoryWorkers say that hospital executives are refusing to fix dire understaffing issues.
Baca lebih lajut »

FDA Approves Updated Non-mRNA COVID Vaccine From NovavaxFDA Approves Updated Non-mRNA COVID Vaccine From NovavaxThe FDA said the Novavax shot is authorized for anyone age 12 and older. Novavax uses a different technology to trigger protection than the mRNA shots made by Pfizer and Moderna. Novavax works similarly to much older vaccines.
Baca lebih lajut »

FDA authorizes Novavax's updated COVID vaccine for fall 2023FDA authorizes Novavax's updated COVID vaccine for fall 2023Many previously vaccinated Americans will be eligible to get Novavax for the first time.
Baca lebih lajut »



Render Time: 2025-03-01 11:42:05